154 related articles for article (PubMed ID: 22751910)
21. [Coagulation and fibrinolysis parameters in disseminated intravascular coagulation (DIC)].
Nakagawa T; Saito H; Watanabe Y; Sato M; Murakawa E
Rinsho Byori; 1991 Mar; 39(3):309-14. PubMed ID: 1828842
[TBL] [Abstract][Full Text] [Related]
22. Elevated levels of prothrombin fragment 1 + 2 indicate high risk of thrombosis.
Ota S; Wada H; Abe Y; Yamada E; Sakaguchi A; Nishioka J; Hatada T; Ishikura K; Yamada N; Sudo A; Uchida A; Nobori T
Clin Appl Thromb Hemost; 2008 Jul; 14(3):279-85. PubMed ID: 18160575
[TBL] [Abstract][Full Text] [Related]
23. Serum albumin levels anticipate antithrombin III activities before and after antithrombin III agent in critical patients with disseminated intravascular coagulation.
Aibiki M; Fukuoka N; Umakoshi K; Ohtsubo S; Kikuchi S
Shock; 2007 Feb; 27(2):139-44. PubMed ID: 17224787
[TBL] [Abstract][Full Text] [Related]
24. Circulating hepatocyte growth factor as an independent prognostic factor of disseminated intravascular coagulation.
Chung S; Kim JE; Kim JY; Lee DS; Han KS; Kim HK
Thromb Res; 2010 Jun; 125(6):e285-93. PubMed ID: 20185166
[TBL] [Abstract][Full Text] [Related]
25. Measurement of soluble fibrin monomer-fibrinogen complex in plasmas derived from patients with various underlying clinical situations.
Nakahara K; Kazahaya Y; Shintani Y; Yamazumi K; Eguchi Y; Koga S; Wada H; Matsuda M
Thromb Haemost; 2003 May; 89(5):832-6. PubMed ID: 12719780
[TBL] [Abstract][Full Text] [Related]
26. Normal prothrombinase activity, increased systemic thrombin activity, and lower antithrombin levels in patients with disseminated intravascular coagulation at an early phase of trauma: comparison with acute coagulopathy of trauma-shock.
Yanagida Y; Gando S; Sawamura A; Hayakawa M; Uegaki S; Kubota N; Homma T; Ono Y; Honma Y; Wada T; Jesmin S
Surgery; 2013 Jul; 154(1):48-57. PubMed ID: 23684364
[TBL] [Abstract][Full Text] [Related]
27. Activation of the coagulation cascade in patients with leptospirosis.
Chierakul W; Tientadakul P; Suputtamongkol Y; Wuthiekanun V; Phimda K; Limpaiboon R; Opartkiattikul N; White NJ; Peacock SJ; Day NP
Clin Infect Dis; 2008 Jan; 46(2):254-60. PubMed ID: 18171258
[TBL] [Abstract][Full Text] [Related]
28. Increased plasma-soluble fibrin monomer levels in patients with disseminated intravascular coagulation.
Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Deguchi H; Mori Y; Kaneko T; Deguchi K; Fujii J; Shiku H
Am J Hematol; 1996 Apr; 51(4):255-60. PubMed ID: 8602623
[TBL] [Abstract][Full Text] [Related]
29. [Evaluation of hypercoagulable state in patients with malignancies by using prothrombin fragment F1 + 2].
Nakagawa K; Tsuji H; Yamada K; Yamada Y; Masuda H; Yamagami M; Yoneda M; Takada O; Sawada S; Kitani T
Rinsho Ketsueki; 1992 Nov; 33(11):1666-72. PubMed ID: 1469781
[TBL] [Abstract][Full Text] [Related]
30. Evaluation the combined diagnostic value of TAT, PIC, tPAIC, and sTM in disseminated intravascular coagulation: A multi-center prospective observational study.
Mei H; Jiang Y; Luo L; Huang R; Su L; Hou M; Wang X; Deng J; Hu Y
Thromb Res; 2019 Jan; 173():20-26. PubMed ID: 30458338
[TBL] [Abstract][Full Text] [Related]
31. Plasma levels of soluble fibrin in patients with malignancy-associated disseminated intravascular coagulation.
Nakagawa K; Tsuji H; Masuda H; Yamada K; Yamada Y; Yoneda M; Takada O; Tamagaki T; Yamagami M; Uno M
Blood Coagul Fibrinolysis; 1994 Oct; 5(5):725-30. PubMed ID: 7865678
[TBL] [Abstract][Full Text] [Related]
32. [Plasma fibrin monitor level in DIC patients with a hematopoietic malignancy].
Hiyoyama K; Wada H; Shimura M; Deguchi H; Nagaya S; Wakita Y; Deguchi K; Shiku H
Rinsho Byori; 1996 Jan; 44(1):57-60. PubMed ID: 8691641
[TBL] [Abstract][Full Text] [Related]
33. Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment.
Dombret H; Scrobohaci ML; Ghorra P; Zini JM; Daniel MT; Castaigne S; Degos L
Leukemia; 1993 Jan; 7(1):2-9. PubMed ID: 8418375
[TBL] [Abstract][Full Text] [Related]
34. Changes in plasma levels of prothrombin fragment F 1 + 2 in cases of disseminated intravascular coagulation.
Asakura H; Shiratori Y; Jokaji H; Saito M; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Matsuda T
Acta Haematol; 1993; 89(1):22-5. PubMed ID: 8480481
[TBL] [Abstract][Full Text] [Related]
35. Hypercoagulability and DIC in high-risk infants.
Suzuki S; Morishita S
Semin Thromb Hemost; 1998; 24(5):463-6. PubMed ID: 9834014
[TBL] [Abstract][Full Text] [Related]
36. Analysis of the cutoff values in fibrin-related markers for the diagnosis of overt DIC.
Hatada T; Wada H; Kawasugi K; Okamoto K; Uchiyama T; Kushimoto S; Seki Y; Okamura T; Imai H; Kaneko T; Nobori T;
Clin Appl Thromb Hemost; 2012 Sep; 18(5):495-500. PubMed ID: 22203032
[TBL] [Abstract][Full Text] [Related]
37. [Clinical relevance of determination of plasma ATIII and alpha 2 PI activities in patients with DIC--application of the molecular markers for the analysis of pathophysiology of DIC].
Okajima K
Rinsho Byori; 1994 Jan; 42(1):45-55. PubMed ID: 8107283
[TBL] [Abstract][Full Text] [Related]
38. Activity and antigen levels of thrombin-activatable fibrinolysis inhibitor in plasma of patients with disseminated intravascular coagulation.
Watanabe R; Wada H; Watanabe Y; Sakakura M; Nakasaki T; Mori Y; Nishikawa M; Gabazza EC; Nobori T; Shiku H
Thromb Res; 2001 Oct; 104(1):1-6. PubMed ID: 11583733
[TBL] [Abstract][Full Text] [Related]
39. Increased soluble fibrin in plasma of patients with disseminated intravascular coagulation.
Wada H; Sase T; Matsumoto T; Kushiya F; Sakakura M; Mori Y; Nishikawa M; Ohnishi K; Nakatani K; Gabazza EC; Shiku H; Nobori T
Clin Appl Thromb Hemost; 2003 Jul; 9(3):233-40. PubMed ID: 14507112
[TBL] [Abstract][Full Text] [Related]
40. Do coagulation screening tests detect increased generation of thrombin and plasmin in sick newborn infants?
Schmidt B; Vegh P; Johnston M; Andrew M; Weitz J
Thromb Haemost; 1993 May; 69(5):418-21. PubMed ID: 8322263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
